Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CYTR $5.01 0.5100 +11.33%
ONCY $0.76 0.0710 +10.29%
FATE $5.96 0.5500 +10.17%
FPRX $24.16 1.6600 +7.38%
AVEO $1.84 0.1200 +6.98%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

BPTH $1.44 -0.1200 -7.69%
KERX $11.45 -0.8300 -6.76%
SNSS $2.64 -0.1800 -6.38%
BDSI $9.46 -0.5600 -5.59%
CLVS $86.15 -4.8400 -5.32%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 877 | 878 | 879 | 880 | 881 | 882 | 883 | 884 | 885 | 886 | Next > | Last >>

Virtual Colonoscopy Still Has Its Skeptics

(USA Today/HealthDay News) Sept 16, 2011 - Whether the most technologically advanced way to check for colon cancer will become the standard screening method of the future does not appear to be a slam-dunk.
read article 



NIH Scientists Find Approach to Enhance and Prolong Immune Attack Against Tumor Cells

(NCI) Sept 19, 2011 - Investigators have identified a new class of human immune cells that behave like stem cells. These cells, a subtype of T lymphocytes, which comprise a small fraction of white blood cells, may prove more effective than any previously reported type of T cell for treating tumors.
read press release 



Docs Light Up Cancer

(ABC News) Sept 19, 2011 - A dye that tracks tumors and glows under fluorescent light helps guide doctors during cancer surgery. Dutch doctors recently used the dye, likened to a homing device, to light up ovarian cancer cells during surgery in a small study of 10 patients.
read article 



Journal of Oncology Practice Study Finds That Concerns about Side Effects, Randomization and Cost Deter Many Cancer Patients from Joining Clinical Trials

(ASCO in Action) Sept 16, 2011 - In a survey that specifically focused on the influence of cost concerns in cancer patients’ decisions to participate in clinical trials, concerns about side effects and randomization outweighed cost as the most common reasons patients declined to participate, though cost was identified as a barrier for more than a quarter of patients.
read article 



Bloodstream Infections May Be Sign of Colon Cancer, Study Says

(Bloomberg) Sept 18, 2011 - Bacterial bloodstream infections may signal colon cancer, according to a study that found people with the infections are 14 times more likely to be diagnosed with the malignancy a year later than the general population.
read article 



FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy

(MarketWatch) Sept 19, 2011 - Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.
read article 



Enzyme Drug Is in Short Supply

(NYT/Prescriptions blog) Sept 15, 2011 - Genzyme’s flagship drug, Cerezyme, is in short supply again.
read article  



Lilly, Novo Drugs’ Cancer Tie Unproven, Researcher Says

(Bloomberg) Sept 16, 2011 - Amylin Pharmaceuticals Inc. and Eli Lilly & Co.’s Byetta and Novo Nordisk A/S’s Victoza, two insulin-raising drugs, don’t appear to carry an increased risk of cancer based on available data, according to a German researcher.
read article 



FDA OKs Early Resubmission of Vivus Diet Drug

(Reuters) Sept 15, 2011 - U.S. health regulators cleared the way for Vivus Inc to submit a new application for a narrower indication of its obesity drug by next month, reviving the possibility of a new prescription fat fighter hitting the market soon.
read article 



FDA Declines To Clear Pfizer Antidepressant For Menopausal Symptoms

(Wall Street Journal) Sept 15, 2011 - Pfizer Inc. said the U.S. Food and Drug Administration declined to approve an application to market the antidepressant Pristiq as a treatment for certain menopausal symptoms such as hot flashes.
read article (paid subscription required) 



Should Doctors Tell Patients When Death is Imminent?

(LAT/Booster Shots blog) Sept 14, 2011 - A study published online this week in the Journal of Clinical Oncology suggests that healthcare professionals keep patients fully informed in the final days and hours of life.
read article (free registration required) 



Millennium Ranked In Top 10 Biotech/Biopharmaceutical Companies For 4th Consecutive Year

(Reuters) Sept 16, 2011 - Millennium: The Takeda Oncology Company today announced that Science magazine has named it among the best biopharmaceutical companies in the world for the fourth consecutive year.
read article 



Health Industry Wish List For Debt Committee

(Reuters) Sept 15, 2011 - President Barack Obama next week will issue proposals for reducing the deficit to Congress, where a "super committee" of Republicans and Democrats is seeking at least $1.2 trillion in savings over a decade, and costly health programs will be considered for cuts.
read article 



Donation Lets KU Reach Funding Goal in Cancer Project

(Kansas City Star) Sept 15, 2011 - The University of Kansas has reached the $61 million goal it wanted before applying for National Cancer Center Institute designation on Sept. 25.
read article 



Inquiry of Wilms Tumor Renewed

(The Times Herald [Port Huron, MI]) Sept 15, 2011 - An investigation into a possible cancer cluster is expected to pick up next month.
read article 



Cancer Testing Lags in Latinos With Family History

(Reuters) Sept 15, 2011 - Latinos were less likely than whites to get screened for colon cancer in a new study from California -- and much less likely when both groups had a family history of the disease.
read article 



Lifestyle Changes Can Benefit Patients with Cancer

(ASCO Post) Sept 15, 2011 - Oncologists may successfully manage their patients with cancer by following treatment guidelines, but they come up short when it comes to prescribing simple measures to enhance their patients' health, according toAnn Partridge, MD, MPH, of Dana-Farber Cancer Institute, Boston, who spoke on the topic at the recent Best of ASCO meeting in Miami.
read article 



Wikipedia Accurate on Cancer Facts, But Hard to Read: Study

(U.S. & World News Report) Sept 15, 2011 - The facts about cancer found on the website Wikipedia are about as accurate as the information on the disease found on the patient-oriented section of the U.S. National Cancer Institute's Physician Data Query (PDQ), a comprehensive peer-reviewed cancer database, according to a new study.
read article 



J&J Honors Genentech Scientist, Holds Meeting on Future of Anti-Angiogenesis Drugs

(Xconomy New York) Sept 15, 2011 - It’s not every day that you see one Big Pharma company handing an award to another, but that’s just what happened yesterday at the New York Academy of Sciences.
read article 



Cephalon Sues Sandoz Over Fentora Cancer Drug

(Reuters) Sept 16, 2011 - Cephalon Inc on Friday sued Novartis AG's Sandoz drug unit, accusing it of trying to infringe two patents related to its Fentora drug that treats pain in adults who have cancer.
read article 



September 2011 Advocacy Update

(ASH) Sept 15, 2011 - New “Super Committee” Meets and Begins Work on Deficit Reduction; 30 Percent Medicare Physician Payment Cut Scheduled to Begin January 1; and more.
read article 



Nation’s Cancer Care Advocates Urge Deficit Committee to Oppose $3 Billion Medicare Cut to Life-Saving Cancer Drugs

(US Oncology) Sept 15, 2011 - In letter to committee, patient advocates, oncologists and cancer care providers explain how potential funding cut would threaten patients’ access to community-based cancer care.
read press release 



DARA BioSciences Reports Strong Results from KRN5500 in Neuropathic Pain

(StreetInsider) Sept 15, 2011 - DARA BioSciences, Inc. announced today that the Company has been selected to present the positive clinical data results for KRN5500, its lead compound for Neuropathic Pain, at the 5th Annual Therapeutics Summit to be held September 20-21, 2011 in San Francisco.
read article 



Study Links Breast Cancer Pain to Fatigue

(UPI) Sept 16, 2011 - Spanish researchers say about 83 percent of those diagnosed with breast cancer survive five years but 66 percent of them suffer fatigue following treatment.
read article 



New Strategy Likely to Speed Drug Development For Rare Cancers

(St. Jude) Sept 15, 2011 - Researchers have identified promising new therapies for ependymoma, a rare tumor with few treatment options.
read press release